Table 3.

Proportion of responders

Outcome	Treatment (n = 201)	Control (n = 99)	p	Odds ratio (95% CI)
Nasal obstruction/congestion score change from baseline to day 30
≥0.5‐point reduction, n/n total (%)	125/199 (62.8)	49/97 (50.5)	0.0440	1.24 (0.99–1.56)
≥1.0‐point reduction, n/n total (%)	88/199 (44.2)	25/97 (25.8)	0.0022	1.72 (1.18–2.49)
Bilateral polyp grade change from baseline to day 90 by clinical investigators
≥1.0‐point reduction, n/n total (%)	144/200 (72.0)	36/98 (36.7)	<0.0001	1.96 (1.49–2.58)
≥2.0‐point reduction , n/n total (%)	95/200 (47.5)	16/98 (16.3)	<0.0001	2.91 (1.82–4.66)

CI = confidence interval.